Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts

Genome Research

Volumn 19, Issue 3, 2009, Pages 381-394

  Sanford, Jeremy R ^a   Wang, Xin ^b   Mort, Matthew ^c   Vanduyn, Natalia ^b   Cooper, David N ^c   Mooney, Sean D ^b   Edenberg, Howard J ^b   Liu, Yunlong ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MICRORNA; MONOCLONAL ANTIBODY; NOVA PROTEIN; PROTEIN; RNA; RNA BINDING PROTEIN; SERINE AND ARGININE RICH PROTEIN; SPLICING FACTOR ARGININE SERINE RICH 1; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CROSS LINKING; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; OPSOCLONUS MYOCLONUS SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RNA SPLICING; RNA TRANSCRIPTION;

ALTERNATIVE SPLICING; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; CONSENSUS SEQUENCE; CROSS-LINKING REAGENTS; DISEASE; DNA, INTERGENIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; INTRONS; MUTATION; NUCLEAR PROTEINS; PROTEIN BINDING; RNA; RNA, UNTRANSLATED; SEQUENCE ANALYSIS, RNA;

METAZOA;

EID: 61849139645     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.082503.108     Document Type: Article

References (79)

1. Bailey, T.L, and Elkan, C. 1995. The value of prior knowledge in discovering motifs with MEME. Proc. Int. Conf. Intell. Syst. Mol. Biol. 3: 21-29.
2. Bailey, T.L., Williams, N., Misleh, C, and Li, W.W. 2006. MEME: Discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res. 34: W369-W373.
3. Barberan-Soler, S. and Zahler, A.M. 2008. Alternative splicing regulation during C. elegans development: Splicing factors as regulated targets. PLoS Genet. 4: e1000001. doi: 10.1371/journal.pgen.1000001.
4. Bejerano, G., Pheasant, M., Makunin, L, Stephen, S., Kent, W.J., Mattick, J.S., and Haussler, D. 2004. Ultraconserved elements in the human genome. Science 304: 1321-1325.
5. Betz, R., Rensing, C, Otto, E., Mincheva, A., Zehnder, D., Lichter, P., and Hildebrandt, F. 2000. Children with ocular motor apraxia type Cogan carry deletions in the gene (NPHP1) for juvenile nephronophthisis. J. Pediatr. 136: 828-831.
6. Brown, V., Jin, P., Ceman, S., Darnell, J.C., O'Donnell, W.T., Tenenbaum, S.A., Jin, X., Feng, Y., Wilkinson, K.D., Keene, J.D., et al. 2001. Microarray identification of FMRP-associated brain mENAs and altered mRNA translational profiles in fragile X syndrome. Cell 107: 477-487.
7. Caceres, J.E, Screaton, G.R., and Krainer, A.R. 1998. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes & Dev. 12: 55-66.
8. Caputi, M., Casari, G., Guenzi, S., Tagliabue, R., Sidoli, A., Melo, C.A., and Baralle, EE. 1994. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22: 1018-1022.
9. Cartegni, L. and Krainer, A.R. 2002. Disruption of an SFRSl-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMNl. Nat. Genet. 30: 377-384.
10. Cavaloc, Y., Bourgeois, C.R, Kister, L., and Stevenin, J. 1999. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA 5: 468-483.
11. Fairbrother, W.G., Yeh, R.F., Sharp, P.A., and Burge, C.B. 2002. Predictive identification of exonic splicing enhancers in human genes. Science 297: 1007-1013.
12. Fairbrother, W.G., Holste, D., Burge, C.B., and Sharp, RA. 2004. Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biol. 2: e268. doi: 10.1371/)journal.pbio.0020268.
13. Felsenstein, J. and Churchill, G.A. 1996. A hidden Markov model approach to variation among sites in rate of evolution. Mol. Biol. Evol. 13: 93-104.
14. Friedman, B.A., Stadler, M.B., Shomron, N., Ding, Y., and Burge, C.B. 2008. Ab initio identification of functionally interacting pairs of ris-regulatory elements. Genome Res. 18: 1643-1651.
15. Fu, X.D. 1993. Specific commitment of different pre-mRNAs to splicing by single SR proteins. Nature 365: 82-85.
16. Gama-Carvalho, M., Barbosa-Morais, N.L., Brodsky, A.S., Silver, P.A., and Carmo-Fonseca, M. 2006. Genome-wide identification of functionally distinct subsets of cellular mRNAs associated with two nucleocvtoplasmic-shuttling mammalian splicing factors. Genome Biol. 7: R113. doi: 10.1186/gb-2006-7-11-r113.
17. Ge, H., Zuo, R, and Manley, J.L. 1991. Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators. Cell 66: 373-382.
18. Gerber, A.P., Herschlag, D., and Brown, P.O. 2004. Extensive association of functionally and cytotopically related mRNAs with Puf family RNA-binding proteins in yeast. PLoS Biol. 2: E79. doi: 10.1371/journal.pbio. 0020079.
19. Ghigna, C, Giordano, S., Shen, H., Benvenuto, E, Castiglioni, E, Comoglio, P.M., Green, M.R., Riva, S., and Biamonti, G. 2005. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol. Cell 20: 881-890.
20. Graveley, B.R. and Maniatis, T. 1998. Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol. Cell 1: 765-771.
21. Graveley, B.R., Hertel, K.J., and Maniatis, T. 2001. The role of U2AF35 and U2AF65 in enhancer-dependent splicing. RNA 7: 806-818.
22. Griffiths-Jones, S., Bateman, A., Marshall, M., Khanna, A., and Eddy, S.R. 2003. Rfam: An RNA family database. Nucleic Acids Res. 31: 439-441.
23. Hanamura, A., Caceres, J.F, Mayeda, A., Franza Jr., B.R., and Krainer, A.R. 1998. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4: 430-444.
24. Hieronymus, H. and Silver, PA. 2003. Genome-wide analysis of RNA-protein interactions illustrates specificity of the mRNA export machinery. Nat. Genet. 33: 155-161.
25. Hosack, D.A., Dennis jr., G., Sherman, B.T., Lane, H.C., and Lempicki, R.A. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol. 4: R70. doi: 10.1186/gb-2003-4-10-r70.
26. Huang, Y. and Steitz, J.A. 2001. Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol. Cell 7: 899-905.
27. Karni, R., de Stanchina, E., Lowe, S.W., Sinha, R., Mu, D., and Krainer, A.R. 2007. The gene encoding the splicing factor SF2/ASF is a protooncogene. Nat. Struct. Mol. Biol. 14: 185-193.
28. Karolchik, D., Kuhn, R.M., Baertsch, R., Barber, G.P., Clawson, H., Diekhans, M., Giardine, B., Harte, R.A., Hinrichs, A.S., Hsu, E, et al. 2008. The UCSC Genome Browser Database: 2008 update. Nucleic Acids Res. 36: D773-D779.
29. Kashima, T. and Manley, J.L. 2003. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet. 34: 460-463.
30. Keene, J.D. 2007. RNA regulons: Coordination of post-transcriptional events. Nat. Rev. Genet. 8: 533-543.
31. Kent, W.J. 2002. BLAT-the BLAST-like alignment tool. Genome Res. 12: 656-664.
32. Kohtz, J.D., Jamison, S.E, Will, C.L., Zuo, P., Luhrmann, R., Garcia-Blanco, M.A., and Manley, J.L. 1994. Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors. Nature 368:119-124.
33. Krainer, A.R., Mayeda, A., Kozak, D., and Binns, G. 1991. Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell 66: 383-394.
34. Lareau, L.F., Inada, M., Green, R.E., Wengrod, J.C., and Brenner, S.E. 2007. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446: 926-929.
35. Lemaire, R., Prasad, J., Kashima, T, Gustafson, J., Manley, J.L., and Lafyatis, R. 2002. Stability of a PKC1-1-related mRNA is controlled by the splicing factor ASF/SF2: A novel function for SR proteins. Genes & Dev. 16: 594-607.
36. Li, X. and Manley, J.L. 2005. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122: 365-378.
37. Lin, S. and Fu, X.D. 2007. SR proteins and related factors in alternative splicing. Adv. Exp. Med. Biol. 623:107-122.
38. Liu, H.X., Zhang, M., and Krainer, A.R. 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes & Dev. 12: 1998-2012.
39. Liu, H.X., Cartegni, L., Zhang, M.Q., and Krainer, A.R. 2001. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet. 27: 55-58.
40. Longman, D., Johnstone, I.E., and Caceres, J.F. 2000. Functional characterization of SR and SR-related genes in Caenorhabditis elegans. EMBO J. 19: 1625-1637.
41. Majewski, J. and Ott, J. 2002. Distribution and characterization of regulatory elements in the human genome. Genome Res. 12: 1827-1836.
42. Maniatis, T. and Tasic, B. 2002. Alternative pre-mRNA splicing and proteome expansion In metazoans. Nature 418: 236-243.
43. Margulies, M., Egholm, M., Aitman, W.E., Attiya, S., Bader, J.S., Bemben, L.A., Berka, J., Braverman, M.S., Chen, Y.J., Chen, Z., et al. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380.
44. Mill, S. and Steitz, J.A. 2004. Evidence for reassociatlon of RNA-binding proteins after cell lysis: Implications for the interpretation of immunopreclpitation analyses. RNA 10: 1692-1694.
45. Moseley, C.T., Mullis, P.E., Prince, M.A., and Phillips 111, j.A. 2002. An exon splice enhancer mutation causes autosomal dominant GH deficiency. J. Clin. Endocrinol. Metab. 87: 847-852.
46. Ni, J.Z., Grate, L., Donohue, J.P., Preston, C, Nobida, N., O'Brien, G., Shiue, L., Clark, T.A., Blume, J.E., and Ares Jr., M. 2007. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes & Dev. 21: 708-718.
47. Olson, S., Blanchette, M., Park, J., Sawa, Y., Yeo, G.W., Yeakley, J.M., Rio, D.C., and Graveley, B.R. 2007. A regulator of Dscam mutually exclusive splicing fidelity. Nat Struct. Mol. Biol 14: 1134-1140.
48. Pagani, K, Buratti, E., Stuani, C., and Baralle, EE. 2003. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J. Biol. Chem. 278: 26580-26588.
49. Parmley, J.L., Chamary, J.V., and Hurst, L.D. 2006. Evidence for purifying selection against synonymous mutations in mammalian exonic splicing enhancers. Mol. Biol. Evol. 23: 301-309.
50. Ramchatesingh, J., Zahler, A.M., Neugebauer, K.M., Roth, M.B., and Cooper, T.A. 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15: 4898-4907.
51. Saltzman, A.L., Kim, Y.K., Pan, Q., Fagnani, M.M., Maquat, L.E., and Blencowe, B.J. 2008. Regulation of multiple core spliceosomal proteins by alternative splicing-coupled nonsense-mediated mRNA decay. Mol. Cell. Biol. 28: 4320-4330.
52. Sanchez-Diaz, P. and Penalva, L.O. 2006. Post-transcription meets post-genomic: The saga of RNA binding proteins in a new era. RNA Biol. 3: 101-109.
53. Sanford, J.R., Gray, N.K., Beckmann, K., and Caceres, J.F. 2004. A novel role for shuttling SR proteins in mRNA translation. Genes & Dev. 18: 755-768.
54. Sanford, J.R., Ellis, J.D., Cazalla, D., and Caceres, J.F. 2005. Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/altemative splicing factor. Proc. Natl. Acad. Sci. 102: 15042-15047.
55. Sanford, J.R., Coutinho, P., Hackett, J.A., Wang, X., Ranahan, W., and Caceres, J.F. 2008. Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASE. PLoS One 3: e3369. doi: 10.1371/journal.pone.0003369.
56. Shen, H. and Green, M.R. 2004. A pathway of sequential arginine-serine-rich domain-splicing signal interactions during mammalian spliceosome assembly. Mol. Cell 16: 363-373.
57. Siepel, A., Bejerano, G., Pedersen, J.S., Hinrichs, A.S., Hou, M., Rosenbloom, K., Clawson, H., Spieth, J., Hillier, L.W., Richards, S., et al. 2005. Evolutionarlly conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15: 1034-1050.
58. Sing, T., Sander, O., Beerenwinkel, N., and Lengauer, T. 2005. ROCR: Visualizing classifier performance in R. Bioinformatics 21: 3940-3941.
59. Smith, P.J., Zhang, C, Wang, J., Chew, S.L., Zhang, M.Q., and Kramer, A.R. 2006. An increased specificity score matrix for the prediction of SFRS1-specific exonic splicing enhancers. Hum. Mol. Genet. 15: 2490-2508.
60. Stenson, P.D., Ball, E.V., Mort, M., Phillips, A.D., Shiel, J.A., Thomas, N.S., Abeyslnghe, S., Krawczak, M., and Cooper, D.N, 2003. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 21: 577-581.
61. Tacke, R. and Manley, J.L. 1995. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14: 3540-3551.
62. Tenenbaum, S.A., Lager, P.J., Carson, C.C., and Keene, J.D. 2002. Ribonomlcs: Identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26: 191-198.
63. Teraoka, S.N., Telatar, M., Becker-Catania, S., Liang, T., Onengut, S., Tolun, A., Chessa, L., Sanal, O., Bernatowska, E., Gatti, R.A., et al. 1999. Splicing defects in the ataxia-telangiectasia gene, ATM: Underlying mutations and consequences. Am. J. Hum. Genet. 64: 1617-1631.
64. Tuerk, C. and Gold, L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
65. Ule, J. and Darnell, R.B. 2006. RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr. Opin. Neurobiol. 16: 102-110.
66. Ule, J., Jensen, K.B., Ruggiu, M., Mele, A., Ule, A., and Darnell, R.B. 2003. CLIP identifies Nova-regulated RNA networks in the brain. Science 302: 1212-1215.
67. Ule, J., Jensen, K., Mele, A., and Darnell, R.B. 2005a. CLIP: A method for identifying protein-RNA interaction sites in living cells. Methods 37: 376-386.
68. Ule, J., Ule, A., Spencer, J., Williams, A., Hu, J.S., Cline, M., Wang, H., Clark, T, Eraser, C, Ruggiu, M., et al. 2005b. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 37: 844-852.
69. Ule, J., Stefani, G., Mele, A., Ruggiu, M., Wang, X., Tanerl, B., Gaasterland, T., Blencowe, B.J., and Darnell, R.B. 2006. An RNA map predicting Nova-dependent splicing regulation. Nature 444: 580-586.
70. Wang, G.S. and Cooper, T.A. 2007. Splicing in disease: Disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 8: 749-761.
71. Wang, Z. and Burge, C.B. 2008. Splicing regulation: From a parts list of regulatory elements to an integrated splicing code. RNA 14: 802-813.
72. Wang, J., Takagaki, Y., and Manley, J.L. 1996. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes & Dev. 10: 2588-2599.
73. Wang, Z., Xiao, X., Van Nostrand, E., and Burge, C.B. 2006. General and specific functions of exonic splicing silencers in splicing control. Mol. Cell 23: 61-70.
74. Wold, B. and Myers, R.M. 2008. Sequence census methods for functional genomics. Nat. Methods 5: 19-21.
75. Xiao, X., Wang, Z., Jang, M., and Burge, C.B. 2007. Coevolutionary networks of splicing cis-regulatory elements. Proc. Natl. Acad. Sci. 104: 18583-18588.
76. Xu, X., Yang, D., Ding, J.H., Wang, W., Chu, P.H., Dalton, N.D., Wang, H.Y., Bermingham Jr., J.R., Ye, Z., Liu, F, et al. 2005. ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120: 59-72.
77. Zhang, X.H. and Chasin, L.A. 2004. Computational definition of sequence motifs governing constitutive exon splicing. Genes & Dev. 18: 1241-1250.
78. Zhang, Z. and Krainer, A.R. 2004. Involvement of SR proteins in mRNA surveillance. Mol. Cell 16: 597-607.
79. Zhang, X.H., Leslie, C.S., and Chasin, L.A. 2005. Dichotomous splicing signals in exon flanks. Genome Res. 15: 768-779.